| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Yaldoo (Laith L)
|
558.386k | 14.58% | +547.264k | Apr 10 2025 |
| 2 |
Maggiore (Christopher D)
|
532.448k | 13.90% | +1.766k | Jan 14 2026 |
| 3 |
Cornell (Alison A)
|
279.481k | 7.30% | +11.709k | Jan 26 2026 |
| 4 |
Strome Mezzanine Fund, L.P.
|
278.639k | 7.28% | +56.134k | Dec 31 2025 |
| 5 |
Strome (Mark E.)
|
194.303k | 5.07% | -26.046k | Dec 31 2025 |
|
1
Yaldoo (Laith L)
|
14.58%
558.386k
|
|
2
Maggiore (Christopher D)
|
13.90%
532.448k
|
|
3
Cornell (Alison A)
|
7.30%
279.481k
|
|
4
Strome Mezzanine Fund, L.P.
|
7.28%
278.639k
|
|
5
Strome (Mark E.)
|
5.07%
194.303k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 48.13% of Zivo Bioscience Inc, with Yaldoo (Laith L) the biggest at 14.58%, followed by Maggiore (Christopher D) (13.90%) and Cornell (Alison A) (7.30%). |
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 16 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 13 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 09 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Oct 04 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 28 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 21 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 16 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 13 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 09 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Oct 04 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 28 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 21 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


